ARCHIVES

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995

Garb’s Questions, Answers About Cancer Program

December 12, 1980

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 12, 1974

32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening

September 21, 1990

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992